K
Khalid Amin
Researcher at University of Minnesota
Publications - 102
Citations - 1948
Khalid Amin is an academic researcher from University of Minnesota. The author has contributed to research in topics: Cancer & Medicine. The author has an hindex of 17, co-authored 86 publications receiving 1750 citations. Previous affiliations of Khalid Amin include SRI International & University of Kansas.
Papers
More filters
Journal ArticleDOI
5'-AMP-activated protein kinase (AMPK) is induced by low-oxygen and glucose deprivation conditions found in solid-tumor microenvironments.
Keith R. Laderoute,Khalid Amin,Joy M. Calaoagan,Merrill Knapp,Theresamai Le,Juan Orduna,Marc Foretz,Benoit Viollet +7 more
TL;DR: Evidence that AMPK is activated in authentic hypoxic tumor microenvironments is obtained and that this activity overlaps with regions of hypoxia detected by a chemical probe, which implies that HIF-1 and AMPK are components of a concerted cellular response to maintain energy homeostasis in low-oxygen or ischemic-tissue microen environments.
Journal ArticleDOI
Erythropoietin receptor expression in adult rat cardiomyocytes is associated with an acute cardioprotective effect for recombinant erythropoietin during ischemia-reperfusion injury.
Gary L. Wright,Paul R. Hanlon,Khalid Amin,Charles Steenbergen,Elizabeth Murphy,Murat O. Arcasoy +5 more
TL;DR: Experiments revealed that the rapid cardioprotective effect of EPO during ischemia‐reperfusion injury was associated with preservation of ATP levels in the ischemic myocardium.
Journal ArticleDOI
A novel role for erythropoietin during fibrin-induced wound-healing response.
TL;DR: A novel function for EPO is demonstrated by providing in vivo evidence for a physiological role during fibrin-induced wound healing and correlated with changes in levels of inducible nitric oxide synthase protein in granulation tissue.
Journal ArticleDOI
Functional Significance of Erythropoietin Receptor Expression in Breast Cancer
Murat O. Arcasoy,Khalid Amin,Aysen F. Karayal,Shu-Chuan Chou,James A. Raleigh,Mahesh A. Varia,Zishan A. Haroon +6 more
TL;DR: Local, one-time administration of a neutralizing anti-EPO antibody, soluble EPO receptor, or an inhibitor of Jak2 resulted in a delay in tumor growth with 45% reduction in maximal tumor depth in tumor Z-chamber model in a dose-dependent manner.
Journal ArticleDOI
Computer-aided rational drug design: a novel agent (SR13668) designed to mimic the unique anticancer mechanisms of dietary indole-3-carbinol to block Akt signaling.
TL;DR: A novel class of indole analogs were used to optimize I3C's anticancer actions, including blocking growth factor-stimulated Akt activation and exhibited potent oral anticancer activity against various cancers and no significant toxicity.